Lupin secures U.S. FDA approval for interchangeable biosimilar Ranibizumab

Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations

Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment

Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe

Abbott secures CE mark for first dual glucose-ketone monitoring systems

Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk

Remidio’s InstaEyeClinic wins first position at Andhra Pradesh MedTech Innovation Challenge

The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

Revenue from operations climbed 13% to Rs. 886.87 crore

Decoding teleophthalmology role in transforming last-mile eye care in India

By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic

Aarti Drugs posts steady FY26 growth & sharp Q4 rebound despite margin pressure

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy

Raay Neo Pharma launches operations to expand access to quality healthcare across India

Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies

Vision 360 brings academia, industry together to advance ophthalmic therapies

VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care